Advertisement
Screener

Evome Medical Technologies, Inc. Comprehensive Income

Evome Medical Technologies, Inc. Comprehensive Income

Evome Medical Technologies, Inc. reported Comprehensive Income of -CAD 15.08 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.

Discontinued › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2024-04-16

  • Evome Medical Technologies, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-12-31 was -15.68M CAD.
  • Evome Medical Technologies, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-09-30 was 3.31M CAD.
  • Evome Medical Technologies, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-06-30 was -1.01M CAD.
  • Evome Medical Technologies, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-03-31 was -1.71M CAD, a 1750.15% decline year-over-year.
  • Evome Medical Technologies, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -15.08M CAD.
  • Evome Medical Technologies, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -4.31M CAD.
  • Evome Medical Technologies, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -3.10M CAD.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 10 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month
2023-12-31-15.68M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
-12.37M CAD
derived: sum of 2 quarters · filed 2024-04-16
-13.38M CAD
derived: sum of 3 quarters · filed 2024-04-16
-15.08M CAD
10-K · filed 2024-04-16
2023-09-303.31M CAD
10-Q · filed 2023-11-14
2.30M CAD
derived: sum of 2 quarters · filed 2023-11-14
596.56K CAD
10-Q · filed 2023-11-14
2023-06-30-1.01M CAD
10-Q · filed 2023-08-14
-2.72M CAD
10-Q · filed 2023-08-14
2023-03-31-1.71M CAD
10-Q · filed 2023-05-15
2022-12-31-15.21M CAD
10-K · filed 2024-04-16
2022-11-30-1.61M CAD
10-Q · filed 2023-01-17
-14.36M CAD
10-Q · filed 2023-01-17
2022-09-30-9.40M CAD
10-Q · filed 2023-11-14
-12.98M CAD
10-Q · filed 2023-11-14
2022-08-31-9.21M CAD
10-Q · filed 2022-10-17
-12.76M CAD
10-Q · filed 2022-10-17
2022-06-30-3.68M CAD
10-Q · filed 2023-08-14
-3.58M CAD
10-Q · filed 2023-08-14
2022-05-31-3.54M CAD
10-Q · filed 2022-07-15
2022-03-31103.33K CAD
10-Q · filed 2023-05-15
2022-02-28-1.21M CAD
derived: 10-KT 12 month − 10-Q 9 month · filed 2023-04-03
-2.61M CAD
derived: sum of 2 quarters · filed 2023-04-03
-3.36M CAD
derived: sum of 3 quarters · filed 2023-04-03
-4.31M CAD
10-KT · filed 2023-04-03
2021-12-31-4.56M CAD
10-KT · filed 2023-04-03
2021-11-30-1.39M CAD
10-Q · filed 2023-01-17
-2.15M CAD
derived: sum of 2 quarters · filed 2023-01-17
-3.09M CAD
10-Q · filed 2023-01-17
-5.05M CAD
derived: sum of 4 quarters · filed 2023-01-17
2021-08-31-756.85K CAD
10-Q · filed 2022-10-17
-1.70M CAD
10-Q · filed 2022-10-17
-3.66M CAD
derived: sum of 3 quarters · filed 2022-10-17
-4.07M CAD
derived: sum of 4 quarters · filed 2022-10-17
2021-05-31-946.72K CAD
10-Q · filed 2022-07-15
-2.91M CAD
derived: sum of 2 quarters · filed 2022-07-15
-3.31M CAD
derived: sum of 3 quarters · filed 2022-07-15
-4.09M CAD
derived: sum of 4 quarters · filed 2022-07-15
2021-02-28-1.96M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31
-2.37M CAD
derived: sum of 2 quarters · filed 2022-05-31
-3.14M CAD
derived: sum of 3 quarters · filed 2022-05-31
-3.10M CAD
10-K · filed 2022-05-31
2020-11-30-406.63K CAD
10-Q · filed 2022-01-14
-1.18M CAD
derived: sum of 2 quarters · filed 2022-01-14
-1.14M CAD
10-Q · filed 2022-01-14
2020-08-31-773.14K CAD
10-Q · filed 2021-10-15
-731.02K CAD
10-Q · filed 2021-10-15
2020-05-3142.12K CAD
10-Q/A · filed 2021-08-02